SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SGNC Sanguine Corp. Info Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sdheart who wrote ()6/16/1998 11:39:00 PM
From: maria  Read Replies (1) of 100
 
Patents filed by Dr. Drees et al.

1. Perfluoro hexamethylenetetramine useful in synthetic blood
Filed Feb. 17, 1989 and issued Feb 13, 1990
patents.ibm.com
(pg 2 of patent gives a background and summary of invention)

2. Compounds of perfluoro[3,3,3]propellene and perfluoro hexamethylenetetramine
Filed Feb. 17, 1989 and issued Sep. 7, 1993
patents.ibm.com

3. Artificial blood containing perfluoro chemicals in presence of emulsifying agents
Filed Aug. 23, 1993 and issued July 18, 1995
patents.ibm.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News